日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Respiratory viral infections awaken metastatic breast cancer cells in lungs.

呼吸道病毒感染会激活肺部转移性乳腺癌细胞

Chia Shi B, Johnson Bryan J, Hu Junxiao, Valença-Pereira Felipe, Chadeau-Hyam Marc, Guntoro Fernando, Montgomery Hugh, Boorgula Meher P, Sreekanth Varsha, Goodspeed Andrew, Davenport Bennett, De Dominici Marco, Zaberezhnyy Vadym, Schleicher Wolfgang E, Gao Dexiang, Cadar Andreia N, Petriz-Otaño Lucia, Papanicolaou Michael, Beheshti Afshin, Baylin Stephen B, Guarnieri Joseph W, Wallace Douglas C, Costello James C, Bartley Jenna M, Morrison Thomas E, Vermeulen Roel, Aguirre-Ghiso Julio A, Rincon Mercedes, DeGregori James

ZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in Cancer.

ZNFX1 在癌症中作为表观遗传诱导的病原体模拟和炎症小体信号传导的主调节因子发挥作用

Stojanovic Lora, Abbotts Rachel, Tripathi Kaushelendra, Coon Collin M, Rajendran Saranya, Abbasi Farid Elnaz, Hostetter Galen, Guarnieri Joseph W, Wallace Douglas C, Liu Sheng, Wan Jun, Calendo Gennaro, Marker Rebecca, Gohari Zahra, Inayatullah Mohammed M A, Tiwari Vijay K, Kader Tanjina, Santagata Sandro, Drapkin Ronny, Kommoss Stefan, Pfisterer Jacobus, Konecny Gottfried E, Coopergard Ryan, Issa Jean-Pierre J, Winterhoff Boris J N, Topper Michael J, Sandusky George E, Miller Kathy D, Baylin Stephen B, Nephew Kenneth P, Rassool Feyruz V

Importance of De Novo Gene Evolution to Emerging Viral Threats: The ORF10 Strain-Restricted Orphan Gene of SARS-CoV-2 Promotes Pathogenesis

从头基因进化对新出现的病毒威胁的重要性:SARS-CoV-2 的 ORF10 毒株特异性孤儿基因促进致病性

Haltom, Jeffrey A; Trovao, Nidia S; Guarnieri, Joseph W; Pan, Vincent; Singh, Urminder; Tsoy, Sergey; O'Leary, Collin A; Bram, Yaron; Widjaja, Gabrielle A; Cen, Zimu; Meller, Robert; Baylin, Stephen B; Moss, Walter N; Nikolau, Basil J; Enguita, Francisco J; Wallace, Douglas C; Beheshti, Afshin; Schwartz, Robert E; Wurtele, Eve Syrkin

Lethal COVID-19 associates with RAAS-induced inflammation for multiple organ damage including mediastinal lymph nodes

致命的 COVID-19 与 RAAS 诱导的炎症有关,可导致包括纵隔淋巴结在内的多器官损伤。

Topper, Michael J; Guarnieri, Joseph W; Haltom, Jeffrey A; Chadburn, Amy; Cope, Henry; Frere, Justin; An, Julia; Borczuk, Alain; Sinha, Saloni; Kim, JangKeun; Park, Jiwoon; Butler, Daniel; Meydan, Cem; Foox, Jonathan; Bram, Yaron; Richard, Stephanie A; Epsi, Nusrat J; Agan, Brian; Chenoweth, Josh G; Simons, Mark P; Tribble, David; Burgess, Timothy; Dalgard, Clifton; Heise, Mark T; Moorman, Nathaniel J; Baxter, Victoria K; Madden, Emily A; Taft-Benz, Sharon A; Anderson, Elizabeth J; Sanders, Wes A; Dickmander, Rebekah J; Beigel, Katherine; Widjaja, Gabrielle A; Janssen, Kevin A; Lie, Timothy; Murdock, Deborah G; Angelin, Alessia; Soto Albrecht, Yentli E; Olali, Arnold Z; Cen, Zimu; Dybas, Joseph; Priebe, Waldemar; Emmett, Mark R; Best, Sonja M; Kelsey Johnson, Maya; Trovao, Nidia S; Clark, Kevin B; Zaksas, Victoria; Meller, Robert; Grabham, Peter; Schisler, Jonathan C; Moraes-Vieira, Pedro M; Pollett, Simon; Mason, Christopher E; Syrkin Wurtele, Eve; Taylor, Deanne; Schwartz, Robert E; Beheshti, Afshin; Wallace, Douglas C; Baylin, Stephen B

A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy

一项针对接受初始免疫检查点抑制剂治疗后进展的转移性尿路上皮癌患者的Guadecitabine联合Atezolizumab II期临床试验

Jang, H Josh; Hostetter, Galen; Macfarlane, Alexander W; Madaj, Zachary; Ross, Eric A; Hinoue, Toshinori; Kulchycki, Justin R; Burgos, Ryan S; Tafseer, Mahvish; Alpaugh, R Katherine; Schwebel, Candice L; Kokate, Rutika; Geynisman, Daniel M; Zibelman, Matthew R; Ghatalia, Pooja; Nichols, Peter W; Chung, Woonbok; Madzo, Jozef; Hahn, Noah M; Quinn, David I; Issa, Jean-Pierre J; Topper, Michael J; Baylin, Stephen B; Shen, Hui; Campbell, Kerry S; Jones, Peter A; Plimack, Elizabeth R

Inhibiting DNA methylation improves antitumor immunity in ovarian cancer

抑制DNA甲基化可增强卵巢癌的抗肿瘤免疫力

Chiappinelli, Katherine B; Baylin, Stephen B

Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine

在接受阿特珠单抗联合愈创木酚甘油醚治疗的复发或难治性MDS或CMML患者中,安全性、疗效和T细胞特征

O'Connell, Casey L; Baer, Maria R; Ørskov, Andreas Due; Saini, Sunil Kumar; Duong, Vu H; Kropf, Patricia; Hansen, Jakob Werner; Tsao-Wei, Denice; Jang, Hyo Sik; Emadi, Ashkan; Holmberg-Thyden, Staffan; Cowland, Jack; Brinker, Brett T; Horwood, Kristin; Burgos, Ryan; Hostetter, Galen; Youngblood, Benjamin A; Hadrup, Sine Reker; Issa, Jean-Pierre; Jones, Peter; Baylin, Stephen B; Siddiqi, Imran; Grønbaek, Kirsten

Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia.

DNA甲基转移酶抑制剂地西他滨和PARP抑制剂他拉唑帕尼联合治疗复发/难治性急性髓系白血病的I期临床试验

Baer Maria R, Kogan Aksinija A, Bentzen Søren M, Mi Tian, Lapidus Rena G, Duong Vu H, Emadi Ashkan, Niyongere Sandrine, O'Connell Casey L, Youngblood Benjamin A, Baylin Stephen B, Rassool Feyruz V

The emerging role of epigenetic therapeutics in immuno-oncology

表观遗传疗法在肿瘤免疫学中的新兴作用

Topper, Michael J; Vaz, Michelle; Marrone, Kristen A; Brahmer, Julie R; Baylin, Stephen B

Biochemical Studies and Molecular Dynamic Simulations Reveal the Molecular Basis of Conformational Changes in DNA Methyltransferase-1.

生物化学研究和分子动力学模拟揭示了DNA甲基转移酶-1构象变化的分子基础

Ye Fei, Kong Xiangqian, Zhang Hao, Liu Yan, Shao Zhiyuan, Jin Jia, Cai Yi, Zhang Rukang, Li Linjuan, Zhang Yang W, Liu Yu-Chih, Zhang Chenhua, Xie Wenbing, Yu Kunqian, Ding Hong, Zhao Kehao, Chen Shijie, Jiang Hualiang, Baylin Stephen B, Luo Cheng